OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
Nia Adeniji, Renumathy Dhanasekaran
Hepatology Communications (2021) Vol. 5, Iss. 12, pp. 1972-1986
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Hepatocellular carcinoma
Arndt Vogel, Tim Meyer, Gonzalo Sapisochín, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1345-1362
Closed Access | Times Cited: 1316

Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
Philip J. Johnson, Qing Zhou, Doan Y Dao, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 10, pp. 670-681
Closed Access | Times Cited: 204

Epigenetic remodelling in human hepatocellular carcinoma
Maria Rita Braghini, Oriana Lo Re, Ilaria Romito, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 50

The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis
Ming‐Cheng Guan, Shiyu Zhang, Qian Ding, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 949-949
Open Access | Times Cited: 28

Clinical applications and perspectives of circulating tumor DNA in gastric cancer
J M Li, Danying Zhang, Ji‐Min Zhu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9

Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring
Mohammed Rifat Shaik, Prem Raj Sagar, Nishat Anjum Shaik, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10644-10644
Open Access | Times Cited: 16

Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review
Edoardogregorio Galli, Giorgio Patelli, Federica Villa, et al.
Cancer Treatment Reviews (2025) Vol. 135, pp. 102908-102908
Open Access

Predicting Liver Cancer Risk Using Comprehensive Medical History
Tumen Sosorburam
Quality Management in Health Care (2025)
Closed Access

Circulating DNA Methylation Profile Improves the Accuracy of Serum Biomarkers for the Detection Of Nonmetastatic Hepatocellular Carcinoma
Thanh Hai Phan, Van Thien Chi Nguyen, Thu Thuy Thi Pham, et al.
Future Oncology (2022) Vol. 18, Iss. 39, pp. 4399-4413
Open Access | Times Cited: 18

Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma
Ashraf Omar, Ahmed O. Kaseb, Tamer Elbaz, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1547-1571
Open Access | Times Cited: 9

Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness Evaluation
Qifeng Chen, Song Chen, Junzhe Yi, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 3

Hepatocellular carcinoma imaging: Exploring traditional techniques and emerging innovations for early intervention
Hariharan Thirumalai Vengateswaran, Mohammad Habeeb, Huay Woon You, et al.
Medicine in Novel Technology and Devices (2024) Vol. 24, pp. 100327-100327
Open Access | Times Cited: 3

Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma
Abdulrahman Hatawsh, Roya Hadi Al-Haddad, Ukamaka Gladys Okafor, et al.
Medical Oncology (2024) Vol. 41, Iss. 12
Closed Access | Times Cited: 3

The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions
Onyinye Ugonabo, Utibe-Abasi Udoh, Pradeep Rajan, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1369-1369
Open Access | Times Cited: 8

Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA
Shifeng Lian, Chenyu Lu, Fugui Li, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 13, pp. 2772-2779
Closed Access | Times Cited: 2

A Single-Step Immunocapture Assay to Quantify HCC Exosomes Using the Highly Sensitive Fluorescence Nanoparticle-Tracking Analysis
Ali Riza Koksal, Nergiz Ekmen, Yücel Aydın, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1935-1954
Open Access | Times Cited: 6

Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma
Siyu Fu, Teoman Deger, Ruben Boers, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4784-4784
Open Access | Times Cited: 5

Evaluation and Prognostication of Gd‐EOB‐DTPA MRI and CT in Patients With Macrotrabecular‐Massive Hepatocellular Carcinoma
Jie Cheng, X. Li, L. Wang, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 59, Iss. 6, pp. 2071-2081
Open Access | Times Cited: 5

Genetic screening of liver cancer: State of the art
Milena Peruhova, Sonya Banova-Chakarova, Dimitrina Georgieva Miteva, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 5, pp. 716-730
Open Access | Times Cited: 1

Circulating DNA genome-wide fragmentation in early detection and disease monitoring of hepatocellular carcinoma
Shifeng Lian, Chenyu Lu, Fugui Li, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109701-109701
Open Access | Times Cited: 1

Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care
Inah Marie C. Aquino, Devis Pascut
Annals of Hepatology (2023) Vol. 29, Iss. 2, pp. 101176-101176
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top